Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 800 shares at $6.25 ($5K) on 2013-01-24, disclosed to the SEC on 2013-01-28.
Open-market purchase of $5k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MEIP | SELL | 2017-11-29 | $24K | — | Filing → |
| MEIP | BUY | 2015-01-23 | $19K | — | Filing → |
| MEIP | BUY | 2015-01-02 | $13K | — | Filing → |